2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Endocrine
1
Conditions
Colorectal Neoplasms
14
Breast Neoplasms
13
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
8
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Prostatic Neoplasms
3
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Colorectal Cancer Screening
2
Carcinoma, Intraductal, Noninfiltrating
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Interventions
relacorilant
5
Nutrition Assessment
4
Hydrochlorothiazide
4
Bevacizumab
3
Amlodipine
3
aliskiren
2
Osilodrostat
2
Lisinopril
2
Labetalol
2
Angiotensin-Converting Enzyme Inhibitors
2
Adrenalectomy
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
ganirelix
1
gallium Ga 68 dotatate
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
benazepril
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Patient Navigation
×
Clear all
NCT01092078
2015-04-22
MISTER-B
NYU Langone Health
Phase NA
Completed
740 enrolled